Chronic kidney disease or CKD, is a condition that builds over time, as a result of inappropriate kidney function. The ...
A recent study published in Hypertension by Kario et al. (2025) provides compelling evidence that radiofrequency renal ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...
In India, a growing number of young adults are showing higher-than-normal uric acid levels, a condition once seen mostly in ...
Researchers have found that the severity of diabetic retinopathy (DR) and the presence of diabetic macular edema (DME) are ...
Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to ...
A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...
New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to ...
A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, will showcase a bold vision for radiology at the Radiological ...
Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback